Bioceres Crop Solutions Corp. (BIOX) Q4 2026 earnings review
Cost cuts return EBITDA to positive, balance sheet still stranded
Bioceres reported Q4 continuing revenue of $55.9 million, up 0.9% year-over-year, and posted $0.6 million in Adjusted EBITDA versus a $9.6 million loss last year. The shift came from a 19% drop in operating expenses and 36% growth in Crop Nutrition. Reported gross margin fell 178 basis points to 22.8%, absorbing a $4.0 million inventory charge.
⚖️ Verdict: 🟢 Bullish
The case is better — a bullish verdict — because strict cost cuts and biologicals growth are stabilizing the core model as the seed business shrinks. Excluding the inventory write-down, clean gross margin expanded over 500 basis points to 29.9% (derived). This operational leverage proves the asset-light strategy is working, despite the unresolved noteholder dispute.
The print did not settle the liquidity risk hanging over the balance sheet. With $11.2 million in cash against $165.9 million in current debt tied to the foreclosure fight, the company's near-term stability relies on legal proceedings rather than operational cash flow.
🐂 Bull Case
Operating Discipline Returns Adjusted EBITDA to Positive
Operating expenses fell 19% to $23.9 million in the quarter, dropping 8.7 points to 42.7% of revenue. This strict cost-cutting allowed Bioceres to post positive Adjusted EBITDA of $0.6 million, a sharp $10.1 million turnaround from last year's $9.6 million loss, even as reported gross profits fell. Management explicitly noted that finding further operating expense efficiencies remains a priority for fiscal 2027.
Crop Nutrition Shields the Top Line
While the core seed business shrinks, the Crop Nutrition segment jumped 36% year-over-year to $23.5 million, carrying the entire top line to a 0.9% gain at $55.9 million. The growth masked lingering weakness elsewhere: Crop Protection fell 7% to $27.7 million, and the Seed and Integrated Products segment dropped 43%. The pivot demonstrates the company's reliance on biologicals and micro-beaded fertilizers while it completes the lengthy reorganization of its HB4 downstream operations.
Core Margins Expanded Before the Inventory Write-Down
While reported gross margin fell 178 basis points to 22.8%, that figure absorbs a $4.0 million non-recurring inventory obsolescence charge. Stripping out that one-time hit, clean gross margin actually expanded to 29.9% (derived), up 532 basis points year-over-year. Management attributed this underlying improvement to better performance across core product categories as the company phases out lower-margin downstream seed sales.
🐻 Bear Case
The Seed Base Continues to Shrink
Management frames the strategic reconfiguration of the HB4 seed business as a successful pivot to a capital-light royalty model, but it continues to erode the top line in the near term. Seed and Integrated Products revenue dropped 43% to $4.8 million this quarter, accounting for half of the company's full-year 18% revenue decline. Though management claims the transition is now substantially complete, the lost direct-sales revenue has yet to be replaced by the promised royalty streams.
The Balance Sheet is Stranded by the Foreclosure Fight
The operational stabilization is overshadowed by an acute liquidity crisis tied to the Pro Farm foreclosure. The company holds just $11.2 million in cash and equivalents against $267.0 million in current liabilities, including $118.6 million in secured notes that remain classified as short-term due to the ongoing dispute with noteholders. Until the legal proceedings over the acceleration of these notes are resolved or the debt is restructured, the continuing operations' cash generation is vastly insufficient to cover the overhang.
💲 Other KPIs
Fell 47.4% year-over-year, reflecting the strategic drawdown of seed stockpiles and a $4.0 million obsolescence adjustment.
Declined 7% year-over-year, marking an improvement from the 18% and 14% drops in the prior two quarters. Represented roughly half of total revenue in the period.
❓ Key Questions
Timing of HB4 Royalty Streams
With the seed reconfiguration substantially complete, when do you expect the new HB4 royalty streams to begin offsetting the revenue lost from direct sales?
Resolution of Debt Acceleration
Can you provide a timeline for resolving the secured notes dispute and removing the short-term classification on the $118.6 million in debt?
Further Inventory Risks
Gross margin expanded strongly when excluding the $4.0 million inventory charge; are there any remaining legacy inventories that could trigger further obsolescence write-downs in fiscal 2027?